Registration Info

This is a 1-day meeting and will provide 6 CE/CME credits.

Conference Registration Fee

Practicing Healthcare Professionals: $129

Non-Clinicians / Medical Office Support Staff / Industry Participants

In order to maintain the clinical nature of the conference, nonclinicians—including, but not limited to, office managers, billing specialists, receptionists, and administrative staff; guests, spouses, friends, and/or family members—may not attend PAINWeekEnd.


Unfortunately, we do not have discounts available on hotel rooms. Please contact the hotel directly should you require accommodations.

Hilton Orlando
6001 Destination Parkway
Orlando, FL 32819

View hotel website >>


Get Directions using Google Maps


Download a printable version of the agenda >>

Faculty and courses are subject to change. Please refer to the online agenda below for the most recent course descriptions.

To view the agenda below, click on the + sign next to the day of the conference to expand the conference agenda. Click on the + signs within the agenda to view the course description, UAN number, and AANP pharmacology credits.

*not certified for credit

Saturday, April 13, 2019


    Coffee will be served.

  • Pain Pathways Made Simple

    In order to successfully clinically manage pain, it is essential to begin with an understanding of the underlying mechanisms responsible for its generation. A skillful approach based upon better knowledge concerning the anatomical structures, pathways, and events that result in pain is more likely to lead to effective clinical management of pain. The discussion will include an overview of medication classes typically considered for pain and the pathways they affect.

    • UAN: 0530-0000-19-041-L01-P
    • AANP Rx Hours: 0.00

  • 3's Company: COX-2 Inhibitors, Medicinal Marijuana, and Opioid Prescribing

    There is much controversy around many aspects of pain treatment, and compelling arguments have focused on both sides of the fence regarding appropriate opioid use and prescribing, legalization of marijuana, and the safety of cox-2 inhibitors. In all 3 cases, there are issues associated with strong positions, although the evidence, when put into practice, is less black and white. For each topic, we will evaluate current literature and debate the clinical, legal, and ethical controversies surrounding recent developments in pain management. Attendees will get a better understanding as presenters debate evidence based application of the cdc guidelines in various clinical settings, evaluate clinical and ethical concerns regarding marijuana for medicinal or recreational use, and take a critical look at the literature and its application when using cox-2 inhibitors for treating pain.

    • UAN: 0530-0000-19-050-L01-P
    • AANP Rx Hours: 0.00
  • When Pain Is Not Sexy: Evaluation and Management of Sexual Pain in Females

    It is estimated that up to 21% of women worldwide experience significant pain during intercourse at some point in their lifetime. Research shows that most women suffer in silence for years before they obtain proper care. Pain during intercourse, or dyspareunia, can be classified into superficial dyspareunia (pain with entry affecting the vulvar vestibule or vaginal introitus) or deep dyspareunia (internal pain with vaginal penetration). Superficial dyspareunia can be associated with vaginal dermatosis, atrophic vaginitis, vulvovaginitis, and vulvodynia, whereas deep dyspareunia is commonly caused by endometriosis, adhesions, fibroids, and cervicitis. Dyspareunia can occur before, during, or following intercourse and can be found along with interstitial cystitis, irritable bowel syndrome, and/or sexual abuse. In spite of the negative impact it has on women’s lives, this condition often goes unrecognized, undiagnosed, and untreated. Many times patients have difficulty discussing this ‘private’ subject with their providers, and providers often do not know how to properly evaluate women for sexual pain. This lecture will discuss many of the myths associated with sexual pain and how sexual pain fits the biopsychosocial model of pain. Useful to all healthcare providers, a comprehensive guideline for the evaluation and management of this disorder will be formulated.

    • UAN: 0530-0000-19-052-L01-P
    • AANP Rx Hours: 0.00



    Lunch will be served.

    Sponsored by SCILEX.

  • Chronic Overlapping Pain Conditions: Evaluation and Management

    Chronic pain is the most prevalent, costly, and disabling health condition in the United States, however, clinicians consistently report low confidence in their ability to evaluation and manage it. Many chronic pain patients report pain in multiple areas of their body simultaneously, termed chronic overlapping pain conditions (COPCs), as well as nonpain comorbidities, such as sleep and mood disorders. Educational programs are needed to guide clinicians in conducting a comprehensive biopsychosocial assessment for COPCs, with includes assessment of common nonpain comorbidities and domains (eg, sleep, mood, fatigue, cognitive impairment, physical and social function), as well as to formulate and employ individualized multimodal treatment regimens that address all pain and nonpain conditions/factors that contribute to an individual’s pain condition.

    • UAN: 0530-0000-19-062-L01-P
    • AANP Rx Hours: 0.00


    Refreshments will be served.

    Sponsored by Emergent BioSolutions.

  • Clinical Pearls: Unraveling the Secrets of Imaging Studies

    Diagnostic testing is an integral component for the differential diagnosis. In routine clinical practice there has been a tendency for clinical examinations to become more cursory, largely influenced by increasing demands of time and patient expectations of technological advances. The end result may arguably lead to an overreliance on technology for basic clinical diagnosis. The purpose of this session is 2-fold. It is meant to provide a review and, for some, an introduction to basic structural and functional studies used for the diagnosis of pain related problems. Attention will also be given to the limitations of such studies and the importance of establishing clinical relevance to their findings. Factors that adversely affect clinical management potentially resulting in failed treatment will be discussed as well as best practices when utilizing such studies to help enhance clinical outcomes for treatment.

    • UAN: 0530-0000-19-039-L01-P
    • AANP Rx Hours: 0.00
  • The 411 on Nonprescription Analgesics: When to Hold ‘Em, When to Fold ‘Em

    Pain is the number one reason why patients seek advice from their pharmacist or primary care provider. Patients very often seek to use a nonprescription analgesic to self-treat a painful complaint, yet often do not understand the exclusions to selftreatment or how to select the best analgesic. Participants in this presentation will learn what nonprescription analgesics are available, indications for use, appropriate dosing and duration of therapy, appropriateness of candidates, and how to monitor and educate patients about their nonprescription analgesic. At this presentation, participants will learn the mechanism of action, indications, adverse effects, and precautions of oral and topical nonprescription analgesics, along with patient counseling points when recommending a nonprescription analgesic.

    • UAN: 0530-0000-19-051-L01-P
    • AANP Rx Hours: 0.70


To accompany and enrich your experience at the PAINWeekEnd conference, be sure to attend one or more of the sponsored programs, which are scheduled during breakfast, lunch, and afternoon "Brain Food" time slots in the schedule. There is NO ADDITIONAL CHARGE to attend these program sessions!